MEMehmet Siddik Evsen

Mehmet Siddik Evsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mehmet Siddik Evsen has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effectiveness of Different Cerclage Indications in Cervical Insufficiency and Perinatal Outcomes: A Single-Centre Retrospective Analysis

    by Senem Yaman Tunc, Yasemin Turan, Nurullah Peker, Fatih Mehmet Findik, Elif Agacayak, İsmail Yıldız, Mehmet Siddik Evsen, Ahmet Yalinkaya

    Preterm birth is associated with perinatal morbidity and mortality, and cervical cerclage is an effective intervention for preventing cervical insufficiency. This retrospective study was conducted to evaluate the effects of maternal, obstetric, and perioperative variables on the prolongation of gestational duration and neonatal outcomes in pregnancies where cerclage was performed. To this end, the medical records of 93 singleton pregnancies in which cervical cerclage was performed were evaluated. The findings showed that gestational age was significantly longer and delivery occurred later in the history-based cerclage, ultrasonographic short cervix, and emergency cerclage groups. Cervical funneling and early removal of the cerclage strongly influenced shorter gestational age and reduced live birth-discharge rates. While obstetric complications contributed to adverse neonatal outcomes, progesterone use and maternal comorbidities were not associated with gestational age at delivery. In conclusion, the success of cerclage is multidimensional; indications and the perioperative process play a decisive role.

  • Open Access

    The Novel Mutations in the FRAS1 Gene: Two Case Report

    by Senem Yaman Tunc, Gamze Akin Evsen, Elif Agacayak, Askin Sen, Mehmet Siddik Evsen

    Fraser Syndrome (FS) is an extremely rare genetic disorder with a strong pattern of inheritability that follows the autosomal recessive fashion; the fundamental clinical features include congenital anomalies such as cryptophthalmos, syndactyly, as well as, renal damage. The FRAS1 gene is one of the principal genes implicated in FS. The role of genetic mutations in the development of FS has not been comprehensively elucidated for the present, and novel mutations are still being identified. Hence, the current article addresses two patients who were clinically diagnosed with Fraser Syndrome and included two unique mutations (c.7777C˃T; (p. Q2593X) and c.9821G˃C; (p. R3274P) that are found in the FRAS1 gene. Both patients had clinical features concerning Fraser Syndrome including renal abnormalities and cryptophthalmos, which addresses the severe phenotype associated with FRAS1 mutations. These two novel mutations discovered have expanded the genetic heterogeneity of Fraser Syndrome and have extended the mutational list of the FRAS1 gene. These outcomes might have a profound impact on the further approaches to the therapy of FS and methods of genetic counseling and diagnosis.

  • Open Access

    Pregnancy Outcomes With Congenital Anomalies In South-Eastern Turkey: A Ten-Year Retrospective Study From A Tertiary Centre

    by Senem Yaman Tunç, Ronahi Polat, Reyhan Gündüz, Mehmet Sait İçen, İsmail Yıldız, Mehmet Sıddık Evsen

    Congenital anomalies are an important cause of infant morbidity and mortality and have a high prevalence, especially in low- and middle-income countries. This retrospective cohort study evaluated the prevalence, distribution, and outcomes of congenital anomalies in Southeast Turkey over a 10-year period and investigated prognostic factors affecting survival. A total of 956 pregnant women referred to a tertiary care centre with suspected or confirmed fetal anomaly between January 2015 and December 2024 were included in the study. Maternal demographic, obstetric and clinical data and fetal characteristics were obtained from hospital records. Anomalies were classified according to organ systems and birth weights were categorised according to World Health Organization definitions. Congenital anomalies were observed in 956 (7.3%) of 13,089 births. Central nervous system anomalies were the most common (44.2%), followed by cystic hygroma (10.3%), cardiac (9.4%) and urinary system anomalies (8.7%). Neural tube defects were present in 31.8% of cases and spina bifida was the dominant type (51.0%). Survival was 89.9% at ≥24 weeks compared to only 1% at less than 24 weeks (p<0.001). Logistic regression identified gestational age as the only independent predictor of survival (OR=0.744, 95% confidence interval:0.555-0.997, p=0.048). These findings emphasise the importance of early diagnosis, prenatal screening and region-specific preventive strategies.

  • Open Access

    4D Transvaginal Ultrasonography as a First-Line Non-Invasive Follow-Up After Hysteroscopic Metroplasty in Dysmorphic Uterus Cases

    by Nurullah Peker, Abdurrahman Sengi, Elif Ucar, Talip Karacor, Ugur Deger, Elif Agacayak, Mehmet Sıddık Evsen

    Aim: This study compared the cost-effectiveness of 4D-transvaginal ultrasonography (TVUSG), hysterosalpingography (HSG), and hysteroscopy (HS) in evaluating postoperative uterine correction in patients who underwent hysteroscopic metroplasty for a dysmorphic uterus. Additionally, pregnancy outcomes following surgery were assessed. Materials and Methods: Thirty-one patients who underwent hysteroscopic metroplasty due to a dysmorphic uterus between July 2023 and June 2024 were retrospectively analysed. Postoperative uterine cavity evaluations were performed using 4D-TVUSG. Alternative imaging modalities (HSG and HS) were compared in terms of invasiveness, feasibility and cost based on official ministry of health data. One-year postoperative pregnancy outcomes were also recorded. Results: 4D-TVUSG was found to be superior to HSG and HS due to its non-invasive nature, ease of use, no need for anaesthesia, and lower cost. Postoperatively, 14 patients (45.2%) achieved pregnancy, of whom 3 (21.4%) experienced miscarriages and 11 (78.6%) had ongoing pregnancies or live births. All patients demonstrated a normalised uterine cavity on follow-up and a 100% surgical success rate. Conclusion: 4D-TVUSG is a reliable, cost-effective, and non-invasive method for postoperative assessment in patients with a dysmorphic uterus undergoing hysteroscopic metroplasty. This is the first study to compare the cost-effectiveness of these three imaging methods, highlighting 4D-TVUSG as a potential first-line follow-up tool in clinical practice.

  • Open Access

    A new technique in laparoscopic abdominal access (Evsen Method, Modified Veress Technique)

    by Mehmet Siddik Evsen, Mehmet Sait Icen, Fatih Mehmet Findik, Senem Yaman Tunc, Elif Ağaçayak, Talip Gul

    Objectives: The most important step in laparoscopic surgery is to safely establish the pneumoperitoneum, especially since approximately half of the complications occur during the initial entry into the abdomen. There is a distinct need to modify the available methods to reduce therate of adverse events in laparoscopic entry. In this study, a modified Veress technique (MVT) or Evsen method is introduced.The aim of this article was to present a modified Veress technique for establishing the pneumoperitoneum. Material and methods: The study was conducted at the Dicle University, Faculty of Medicine, Department of Obstetrics and Gynecology, from September 2016 to May 2017. A new laparoscopic entry technique was introduced and compared with the classical Veress technique. A total of 40 cases were included in the study. MVT and the classical Veress method were applied to 26 and 14 patients, respectively. Results: The pneumoperitoneum was established at the first attempt in 23 (88.5%) MVT patients and in 7 (50%) patients from the classical Veress method group. The number of insufflation attempts to establish a successful pneumoperitoneum was lower using MVT and the difference was statistically significant (p: 0.022). As far as time is concerned, a comparison between the groups revealed that the pneumoperitoneum was established in a statistically significantly shorter time using MVT (p < 0.00). Conclusions: The modified Veress technique proved to be superior to the classical Veress method for establishing the pneumoperitoneum. Using the new method, the pneumoperitoneum was established after fewer attempts and in a shorter time. Objectives: The most important step in laparoscopic surgery is to safely establish the pneumoperitoneum, especially since approximately half of the complications occur during the initial entry into the abdomen. There is a distinct need to modify the available methods to reduce therate of adverse events in laparoscopic entry. In this study, a modified Veress technique (MVT) or Evsen method is introduced.The aim of this article was to present a modified Veress technique for establishing the pneumoperitoneum. Material and methods: The study was conducted at the Dicle University, Faculty of Medicine, Department of Obstetrics and Gynecology, from September 2016 to May 2017. A new laparoscopic entry technique was introduced and compared with the classical Veress technique. A total of 40 cases were included in the study. MVT and the classical Veress method were applied to 26 and 14 patients, respectively. Results: The pneumoperitoneum was established at the first attempt in 23 (88.5%) MVT patients and in 7 (50%) patients from the classical Veress method group. The number of insufflation attempts to establish a successful pneumoperitoneum was lower using MVT and the difference was statistically significant (p: 0.022). As far as time is concerned, a comparison between the groups revealed that the pneumoperitoneum was established in a statistically significantly shorter time using MVT (p < 0.00). Conclusions: The modified Veress technique proved to be superior to the classical Veress method for establishing the pneumoperitoneum. Using the new method, the pneumoperitoneum was established after fewer attempts and in a shorter time.


    • 1 July 2013
      • Vol. 17  (14) , 1869-73

    Effects of estrogen, estrogen/progesteron combination and genistein treatments on oxidant/antioxidant status in the brain of ovariectomized rats.

    by M S Evsen, A Ozler, C Gocmez, S Varol, S Y Tunc, E Akil, E Uzar, I Kaplan

    The aim of this study was to investigate the antioxidative effects of estradiol (E), E plus progesteron (P) combination (E/P) and genistein (G) treatment in the brain of ovariectomized (OVX) rats. Adult female Sprague-Dawley rats were divided into five groups, with each group including ten rats. Rats were anesthetized and bilateral ovariectomy was performed under general anaesthesia in all groups except for the sham operation group. Groups included: Sham-operated, control (OVX), estrogen treated group (OVX+ E), E/P combination group (OVX+E/P) and G treated group (OVX+G). Treatments were applied for 8 weeks. The total anti-oxidant status (TAS), total oxidant status (TOS), nitric oxide level (NO), glutathione peroxidase activity (GSH-Px) and oxidative stress index (OSI) were analysed in the brain tissue of rats from each treatment category. Ovariectomy lead to an increase in brain TOS and OSI levels compared to the sham group (p < 0.05). Also, ovariectomy resulted in a decrease in brain TAS levels compared to the sham group that approached statistical significance (p = 0.078). Significant decreases in TOS, OSI, GSH-Px and a significant increases in TAS and NO levels were observed in the E-treatment group compared to the control group (p < 0.001). The E/P combination group exhibited a significantly decreased TOS and OSI and significantly increased TAS and NO levels relative to the control group (p < 0.05). Genistein treatment resulted in a significant decrease in TOS and OSI compared to the control group (p < 0.05). Oxidative stress markers increase in the brain tissue of OVX rats. Conversely, estradiol, E/P and G supplementation decreases oxidative stress markers and increases antioxidant activity. Using G may prevent neural pathologies result in menopause-related oxidative stress.